Research Sheds Light on Dopamine Synapses, Brain Disorders

Abstract

Dopamine synapses play a crucial role in volitional movement and reward-related behaviors, while dysfunction of dopamine synapses causes various psychiatric and neurological disorders. Despite this significance, the true biological nature of dopamine synapses remains poorly understood. Here, we show that dopamine transmission is strongly correlated with GABA co-transmission across the brain and dopamine synapses are structured and function like GABAergic synapses with marked regional heterogeneity. In addition, GABAergic-like dopamine synapses are clustered on the dendrites, and GABA transmission at dopamine synapses has distinct physiological properties. Interestingly, the knockdown of neuroligin-2, a key postsynaptic protein at GABAergic synapses, unexpectedly does not weaken GABA co-transmission but instead facilitates it at dopamine synapses in the striatal neurons. More importantly, the attenuation of GABA co-transmission precedes deficits in dopaminergic transmission in animal models of Parkinson's disease. Our findings reveal the spatial and functional nature of GABAergic-like dopamine synapses in health and disease.

In a groundbreaking study, researchers at UNIST have uncovered a significant characteristic of dopamine synapses, shedding light on their role in volitional movement, reward-related behaviors, and their association with various psychiatric and neurological disorders. The findings, published in the esteemed academic journal Cell Reports, provide crucial insights into the biological nature of dopamine synapses and their potential implications for early detection and treatment of dopamine-related brain diseases such as Parkinson's disease.

Dopamine synapses, responsible for the transmission of dopamine, one of the brain's primary neurotransmitters, have long been the subject of scientific inquiry. However, their true biological nature has remained elusive until now. Led by Professor Jae-Ick Kim from the Department of Biological Sciences at UNIST, the research team has discovered that dopamine synapses exhibit remarkable similarities to inhibitory synapses, which utilize the neurotransmitter gamma-aminobutyric acid (GABA) to inhibit excessive neuronal activity.

GABA co-transmission co-exists with DA transmission at DA synapses in the brain

Figure 1. GABA co-transmission co-exists with DA transmission at DA synapses in the brain. (A) Schematic illustration depicting electrophysiological recording of synaptic transmission at DA synapses in the multiple brain regions, (B-C) Representative recording traces and summary statistics of DA transmission in the brain (n = 12-32 slices), and (D-E) Representative recording traces and summary statistics of GABA transmission at DA synapses (n = 7-17 cells).

The team's findings demonstrate a strong correlation between dopamine transmission and GABA co-transmission across the brain, unveiling the structured and functional nature of GABAergic-like dopamine synapses. These synapses exhibit marked regional heterogeneity and are clustered on the dendrites, providing important insights into their spatial organization. Moreover, the study reveals distinct physiological properties of GABA transmission at dopamine synapses.

Surprisingly, the knockdown of neuroligin-2, a key postsynaptic protein at GABAergic synapses, does not weaken GABA co-transmission but instead facilitates it at dopamine synapses in striatal neurons. This unexpected result highlights the intricate interplay between neurotransmitters and synaptic proteins, further deepening our understanding of dopamine synapses' functionality.

In an animal model of Parkinson's disease, the researchers discovered that the attenuation of GABA co-transmission precedes deficits in dopaminergic transmission. This finding suggests that monitoring GABA levels could potentially serve as an early indicator of Parkinson's disease progression. The study also experimentally confirmed the possibility that supplementing reduced GABA could slow the advancement of Parkinson's disease, opening new avenues for treatment development.

Figure 2. GABAergic-like DA synapse

Figure 2. GABAergic-like DA synapse

"By measuring neurotransmitters such as dopamine and GABA and improving high-resolution synaptic imaging methods, we were able to identify new physiological properties of dopamine synapses," explained the first author Hyun-Jin Kim (Department of Biological Sciences, UNIST). "Our research reveals the crucial role of inhibitory synapse properties within dopamine synapses, contributing to their survival."

Professor Kim emphasized the significance of the study's findings, stating, "Understanding the unique properties of dopamine synapses will not only aid in the early detection of dopamine-related brain diseases but also pave the way for the development of targeted treatments, particularly for Parkinson's disease."

This study has been supported by the Ministry of Science and ICT (MSIT), the National Research Foundation of Korea (NRF), and the POSCO Science Fellowship of the POSCO TJ Park Foundation.

Journal Reference

Hyun-Jin Kim, Byungjae Hwang, Maria Reva, et al., "GABAergic-like dopamine synapses in the brain," Cell Reports, (2023).

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.